Abstract
Interactions of aminoglycosides with phospholipids were estimated by the increase in turbidity of liposomes consisting of various phospholipids. The turbidity of liposomes containing negatively charged phospholipids was increased by gentamicin, the highest increase in turbidity being observed for phosphatidylinositol-4,5-diphosphate-containing liposomes. The extent of turbidity was dependent on the concentration of acidic phospholipid in the liposomal membrane as well as the number of amino groups of the aminoglycosides. The release of glucose from glucose-entrapped liposomes depended on the concentration of gentamicin. The turbidity of liposomes containing lipids extracted from rat renal cortex was also increased by aminoglycosides depending on the number of amino groups. From electron microscopic observations, the increase in turbidity of liposome suspensions was caused by liposome fusion.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
G. J. Kaloyanides and E. Pastoriza-Munoz. Kidney Int. 18:571–582 (1980).
F. J. Silverblatt and C. Kuehn. Kidney Int. 15:335–345 (1979).
R. P. Wedeen, V. Batuman, C. Cheeks, E. Marquet, and H. Sobel. Lab. Invest. 48:213–223 (1983).
Y. Aramaki, M. Takahashi, A. Inaba, and S. Tsuchiya. Biochim. Biophys. Acta 862:111–118 (1986).
M. Sastrashinh, T. C. Knauss, J. M. Weinberg, and H. D. Humes. J. Pharmacol. Exp. Ther. 222:350–358 (1982).
T. Deguchi, A. Ishii, and M. Tanaka. J. Antibiot. 31:150–155 (1978).
Y. Aramaki, J. Niibuchi, S. Tsuchiya, and J. Hosoda. Chem. Pharm. Bull. 35:320–325 (1987).
Y. Aramaki, A. Inaba, J. Hosoda, and S. Tsuchiya. Chem. Pharm. Bull. 35:756–760 (1987).
A. Inaba, Y. Aramaki, M. Takahashi, and S. Tsuchiya. Life Sci. 39:1345–1351 (1986).
M. W. Yung and C. Green. Biochem. Pharmacol. 35:4037–4041 (1986).
M. W. Yung and C. Green. J. Antibiot. 40:862–867 (1987).
P. S. Chen, T. Y. Toribara, and H. Warner. Anal. Chem. 28:1756–1758 (1956).
M. Dubois, K. A. Gilles, J. K. Hamilton, P. A. Rovers, and F. Smith. Anal. Chem. 28:350–356 (1956).
J. Folch, M. Lees, and G. H. Sloane-Stanley. J. Biol. Chem. 226:497–509 (1957).
J. J. Lipsky, L. Cheng, B. Sacktor, and P. S. Lietman. J. Pharmacol. Exp. Ther. 215:390–393 (1980).
Y. Ishikawa, K. Inui, and R. Hori. J. Pharmacobio-Dyn. 8:931–941 (1985).
P. D. Williams, H. Hottendorf, and D. B. Bennett. J. Pharmacol. Exp. Ther. 237:919–925 (1986).
A. Inaba, Y. Aramaki, K. Takeda, and S. Tsuchiya. Chem. Pharm. Bull. 32:3173–3178 (1984).
G. Viotte, B. Olier, J. P. Morin, J. Hemet, and J. P. Fillastre. Drugs Exp. Clin. Res. 9:735–747 (1983).
N. Briom, J. Barge, I. Godefroy, F. Dromer, C. Dubois, A. Contrepois, and C. Carbon. Antimicrob. Agents Chemother. 25:168–172 (1984).
M. Takahashi, Y. Aramaki, A. Inaba, and S. Tsuchiya. Biochim. Biophys. Acta 903:31–36 (1987).
J. H. Wiessner, H. Mar, D. G. Baskin, and K. J. Hwag. J. Pharm. Sci. 75:259–263 (1986).
S. Au, N. D. Wener, and J. Schacht. Biochim. Biophys. Acta 902:80–86 (1987).
M. Berridge. Biochem. J. 220:345–360 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aramaki, Y., Tsuchiya, S. Interactions Between Aminoglycosides and Phospholipids Using Liposomes: A Possible Mechanism of Nephrotoxicity. Pharm Res 6, 362–366 (1989). https://doi.org/10.1023/A:1015919129091
Issue Date:
DOI: https://doi.org/10.1023/A:1015919129091